| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-47 |
Sentence |
denotes |
Antibody recognition of carbohydrate epitopes†. |
| T1 |
0-47 |
Sentence |
denotes |
Antibody recognition of carbohydrate epitopes†. |
| T1 |
0-47 |
Sentence |
denotes |
Antibody recognition of carbohydrate epitopes†. |
| TextSentencer_T2 |
48-234 |
Sentence |
denotes |
Carbohydrate antigens are valuable as components of vaccines for bacterial infectious agents and human immunodeficiency virus (HIV), and for generating immunotherapeutics against cancer. |
| T2 |
48-234 |
Sentence |
denotes |
Carbohydrate antigens are valuable as components of vaccines for bacterial infectious agents and human immunodeficiency virus (HIV), and for generating immunotherapeutics against cancer. |
| T2 |
48-234 |
Sentence |
denotes |
Carbohydrate antigens are valuable as components of vaccines for bacterial infectious agents and human immunodeficiency virus (HIV), and for generating immunotherapeutics against cancer. |
| TextSentencer_T3 |
235-452 |
Sentence |
denotes |
The crystal structures of anti-carbohydrate antibodies in complex with antigen reveal the key features of antigen recognition and provide information that can guide the design of vaccines, particularly synthetic ones. |
| T3 |
235-452 |
Sentence |
denotes |
The crystal structures of anti-carbohydrate antibodies in complex with antigen reveal the key features of antigen recognition and provide information that can guide the design of vaccines, particularly synthetic ones. |
| T3 |
235-452 |
Sentence |
denotes |
The crystal structures of anti-carbohydrate antibodies in complex with antigen reveal the key features of antigen recognition and provide information that can guide the design of vaccines, particularly synthetic ones. |
| TextSentencer_T4 |
453-927 |
Sentence |
denotes |
This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides. |
| T4 |
453-927 |
Sentence |
denotes |
This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides. |
| T4 |
453-927 |
Sentence |
denotes |
This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides. |
